ABSTRACT
ABSTRACTPurpose:To assess whether retinal and central nervous system (CNS) comorbidities are risk factors for complications following robotic assisted laparoscopic prostatectomy (RALP).Materials and Methods:A retrospective review of our RALP database identified 1868 patients who underwent RALP by a single surgeon between December 10, 2003-March 14, 2014. We hypothesized that patients with preexisting retinal or CNS comorbidities were at a greater risk of suffering retinal and CNS complications following RALP. Perioperative complications and risk of recurrence were graded using the Clavien and D'Amico systems, respectively.Results:40 (2.1%) patients had retinal or CNS-related comorbidities, of which 15 had a history of retinal surgery and 24 had a history of cerebrovascular accident, aneurysm and/or neurosurgery. One additional patient had a history of both retinal and CNS events.Patients with retinal or CNS comorbidities were significantly older, had elevated PSA levels and CCI (Charlson Comorbidity Index) scores than the control group. Blood loss, length of stay, surgical duration, BMI, diagnostic Gleason score and T-stage were not statistically different between groups.No retinal or CNS complications occurred in either group. The distribution of patients between D'Amico risk categories was not statistically different between the groups. There was also no difference in the incidence of total complications between the groups.Conclusions:RALP-associated retinal and CNS complications are rare. While our RALP database is large, the cohort of patients with retinal or CNS-related comorbidities was relatively small. Our dataset suggests retinal and CNS pathology presents no greater risk of suffering from perioperative complications following RALP.
Subject(s)
Aged , Humans , Male , Middle Aged , Laparoscopy/methods , Postoperative Complications/etiology , Prostatectomy/adverse effects , Retinal Diseases/etiology , Robotic Surgical Procedures/adverse effects , Stroke/etiology , Comorbidity , Central Nervous System Diseases/epidemiology , Central Nervous System Diseases/etiology , Head-Down Tilt/adverse effects , Incidence , Operative Time , Optic Neuropathy, Ischemic/epidemiology , Optic Neuropathy, Ischemic/etiology , Perioperative Period , Prostatectomy/methods , Retrospective Studies , Risk Factors , Retinal Diseases/epidemiology , Statistics, Nonparametric , Stroke/epidemiologyABSTRACT
La pérdida de visión post cirugía cardíaca es una complicación infrecuente, pero devastadora. La incidencia reportada es variable. Realizamos una búsqueda bibliográfica de la evidencia disponible para describir su incidencia y los potenciales factores de riesgo. Se identificó una incidencia muy variable, de 0.001 por ciento a 1.3 por ciento. La causa reportada más frecuente corresponde a la neuropatía óptica isquémica. El factor de riesgo personal más significativo fue la enfermedad vascular clínica severa. Dentro de los factores de riesgo intraoperatorios, el grado de anemia, la hipotensión y la duración de la circulación extracorpórea fueron los con mayor significancia en las distintas series. Aunque la incidencia de esta complicación es baja, dada su gravedad debiera ser considerada para advertir a los pacientes con mayor riesgo preoperatorio y tratar de minimizar los factores intraoperatorios.
Lost of vision after cardiac surgery is a rare but a devastating complication. The reported incidence is variable.In order to describe its incidence and potential risk factors, we directed a bibliographic search of available evidence. A very variable incidence was identified, ranging from 0.001 percent to 1.3 percent. The most frecuent cause published was ischemic optic neuropathy. The most meningfull personal risk factor was clinically severe vascular disease. Among intraoperatory risk factors, the ones with the most significance in different series were anemia, hypotension and duration of extracorporeal circulation. Although the incidence of this complication is low, given its seriousness, it should be informed to patients with the highest preoperative risk, and intraoperatory factors should be reduced to a minimum.